Cargando…

MicroRNA 3928 Suppresses Glioblastoma through Downregulation of Several Oncogenes and Upregulation of p53

Glioblastoma (GBM) is the most frequent and lethal primary malignant brain tumor. Despite decades of research, therapeutic advances that significantly prolong life are non-existent. In recent years, microRNAs (miRNAs) have been a focus of study in the pathobiology of cancer because of their ability...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mulcahy, Elizabeth Q. X., Zhang, Ying, Colόn, Rossymar R., Cain, Shelby R., Gibert, Myron K., Dube, Collin J., Hafner, Markus, Abounader, Roger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8998958/ https://www.ncbi.nlm.nih.gov/pubmed/35409289 http://dx.doi.org/10.3390/ijms23073930

Ejemplares similares

HGF/MET Signaling in Malignant Brain Tumors
por: Mulcahy, Elizabeth Qian Xu, et al.
Publicado: (2020)

The p53 Pathway in Glioblastoma
por: Zhang, Ying, et al.
Publicado: (2018)

miR-3174 Is a New Tumor Suppressor MicroRNA That Inhibits Several Tumor-Promoting Genes in Glioblastoma
por: Hanif, Farina, et al.
Publicado: (2023)

Role and Therapeutic Targeting of the HGF/MET Pathway in Glioblastoma
por: Cruickshanks, Nichola, et al.
Publicado: (2017)

MDB-30. IDENTIFICATION AND CHARACTERIZATION OF NOVEL TRANSCRIBED ULTRACONSERVED REGIONS AS LONG NON-CODING RNAS IN MEDULLOBLASTOMA
por: Hudson, Kadie, et al.
Publicado: (2023)

Transcribed Ultraconserved Regions in Cancer
por: Gibert, Myron K., et al.
Publicado: (2022)

In vitro/vivo Mechanism of Action of MP1102 With Low/Nonresistance Against Streptococcus suis Type 2 Strain CVCC 3928
por: Zhao, Fei, et al.
Publicado: (2019)

CRKL oncogene is downregulated by p53 through miR-200s
por: Tamura, Miyuki, et al.
Publicado: (2015)

Oncogenic Gain of Function in Glioblastoma Is Linked to Mutant p53 Amyloid Oligomers
por: Pedrote, Murilo M., et al.
Publicado: (2020)

A new class of radiosensitizers for glioblastoma
por: Abounader, Roger, et al.
Publicado: (2021)

miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3
por: Zhang, Qiaoge, et al.
Publicado: (2018)

Oncogenic Ras is downregulated by ARHI and induces autophagy by Ras/AKT/mTOR pathway in glioblastoma
por: Zhong, Chen, et al.
Publicado: (2019)

Correction to: miR-3928v is induced by HBx via NF-κB/EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3
por: Zhang, Qiaoge, et al.
Publicado: (2020)

Retraction Note: miR-3928v is induced by HBx via NF-κB/ EGR1 and contributes to hepatocellular carcinoma malignancy by down-regulating VDAC3
por: Zhang, Qiaoge, et al.
Publicado: (2022)

Annexin‐1 is an oncogene in glioblastoma and causes tumour immune escape through the indirect upregulation of interleukin‐8
por: Chen, Rui, et al.
Publicado: (2022)

Cytoplasmic p53 couples oncogene-driven glucose metabolism to apoptosis and is a therapeutic target in glioblastoma
por: Mai, Wilson X., et al.
Publicado: (2017)

TP53: an oncogene in disguise
por: Soussi, T, et al.
Publicado: (2015)

Targeting Wnt/β-catenin-mediated upregulation of oncogenic NLGN3 suppresses cancer stem cells in glioblastoma
por: Yun, Eun-Jin, et al.
Publicado: (2023)

HBV-encoded miR-2 functions as an oncogene by downregulating TRIM35 but upregulating RAN in liver cancer cells
por: Yao, Lili, et al.
Publicado: (2019)

Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma
por: Fadhil, Rushdi S., et al.
Publicado: (2020)

Oncogenic activity of SOX1 in glioblastoma
por: Garcia, Idoia, et al.
Publicado: (2017)

The oncogenic roles of 27-hydroxycholesterol in glioblastoma
por: Liu, Lu, et al.
Publicado: (2019)

EZH2 inhibition in multiple myeloma downregulates myeloma associated oncogenes and upregulates microRNAs with potential tumor suppressor functions
por: Alzrigat, Mohammad, et al.
Publicado: (2016)

NBM-BMX, an HDAC8 Inhibitor, Overcomes Temozolomide Resistance in Glioblastoma Multiforme by Downregulating the β-Catenin/c-Myc/SOX2 Pathway and Upregulating p53-Mediated MGMT Inhibition
por: Tsai, Cheng-Yu, et al.
Publicado: (2021)

Overexpression of miR-29a reduces the oncogenic properties of glioblastoma stem cells by downregulating Quaking gene isoform 6
por: Xi, Zhuo, et al.
Publicado: (2017)

Oncogenic Role of Merlin/NF2 in Glioblastoma
por: Guerrero, Paola A., et al.
Publicado: (2014)

EPS8 is a Potential Oncogene in Glioblastoma
por: Yang, Gang, et al.
Publicado: (2019)

Distinct oncogenic phenotypes in hematopoietic specific deletions of Trp53
por: Palanichamy, Jayanth Kumar, et al.
Publicado: (2023)

How TP53 (almost) became an oncogene
por: Weinberg, Robert A
Publicado: (2019)

Do Mutations Turn p53 into an Oncogene?
por: Pitolli, Consuelo, et al.
Publicado: (2019)

Expression of lncRNAs in Low-Grade Gliomas and Glioblastoma Multiforme: An In Silico Analysis
por: Reon, Brian J., et al.
Publicado: (2016)

Downregulation of Sirt1 is correlated to upregulation of p53 and increased apoptosis in epicardial adipose tissue of patients with coronary artery disease
por: Khanahmadi, Mahdieh, et al.
Publicado: (2020)

C1-inactivator is upregulated in glioblastoma
por: Förnvik, Karolina, et al.
Publicado: (2017)

Oncogenic KRAS drives radioresistance through upregulation of NRF2-53BP1-mediated non-homologous end-joining repair
por: Yang, Linlin, et al.
Publicado: (2021)

PBA Preferentially Impairs Cell Survival of Glioblastomas Carrying mutp53 by Reducing Its Expression Level, Stabilizing wtp53, Downregulating the Mevalonate Kinase and Dysregulating UPR
por: Romeo, Maria Anele, et al.
Publicado: (2020)

Antitumor Effects of Ral-GTPases Downregulation in Glioblastoma
por: Cemeli, Tània, et al.
Publicado: (2022)

Comprehensive Oncogenic Features of Coronavirus Receptors in Glioblastoma Multiforme
por: Chen, Anjing, et al.
Publicado: (2022)

Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
por: Lee, Haksoo, et al.
Publicado: (2022)

Jdp2 downregulates Trp53 transcription to promote leukaemogenesis in the context of Trp53 heterozygosity
por: van der Weyden, L, et al.
Publicado: (2013)

Berbamine induces SMMC-7721 cell apoptosis via upregulating p53, downregulating survivin expression and activating mitochondria signaling pathway
por: Cao, Ying, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_aga9u1qu3hpbnlrdm4eu2hvarl